32,164 Shares in Envista Holdings Corporation $NVST Bought by Diversified Trust Co

Diversified Trust Co purchased a new position in shares of Envista Holdings Corporation (NYSE:NVST – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 32,164 shares of the company’s stock, valued at approximately $755,000.

A number of other hedge funds have also added to or reduced their stakes in the company. Covestor Ltd increased its stake in Envista by 14.9% in the third quarter. Covestor Ltd now owns 3,882 shares of the company’s stock valued at $91,000 after acquiring an additional 502 shares during the last quarter. Parallel Advisors LLC lifted its stake in Envista by 16.9% during the first quarter. Parallel Advisors LLC now owns 3,710 shares of the company’s stock worth $94,000 after purchasing an additional 535 shares during the last quarter. Tidal Investments LLC lifted its stake in Envista by 2.4% during the second quarter. Tidal Investments LLC now owns 23,555 shares of the company’s stock worth $621,000 after purchasing an additional 547 shares during the last quarter. Abel Hall LLC lifted its stake in Envista by 4.7% during the third quarter. Abel Hall LLC now owns 12,513 shares of the company’s stock worth $294,000 after purchasing an additional 562 shares during the last quarter. Finally, CenterBook Partners LP lifted its stake in Envista by 2.2% during the third quarter. CenterBook Partners LP now owns 26,441 shares of the company’s stock worth $621,000 after purchasing an additional 581 shares during the last quarter.

Analyst Ratings Changes

A number of brokerages have weighed in on NVST. Needham & Company LLC reaffirmed a “hold” rating on shares of Envista in a report on Thursday, November 5th. Morgan Stanley set a $23.00 price target on Envista in a report on Thursday, August 6th. JPMorgan Chase & Co. upgraded Envista from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $29.00 to $32.00 in a research report on Thursday, September 3rd. Piper Sandler dropped their price objective on Envista from $28.00 to $26.00 and set a “neutral” rating for the company in a research report on Friday, October 9th. Finally, Zacks Research lowered Envista from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Six analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $29.00.

Check Out Our Latest Report on Envista

Insider Activity at Envista

In other news, SVP Mischa Reis sold 8,000 shares of the stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $27.50, for a total value of $220,000.00. Following the completion of the transaction, the senior vice president directly owned 27,321 shares in the company, valued at approximately $751,327.50. This represents a 22.65% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.99% of the company’s stock.

Envista Price Performance

Shares of NYSE:NVST opened at $23.71 on Wednesday. Envista Holdings Corporation has a one year low of $18.77 and a one year high of $30.42. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.45 and a quick ratio of 2.10. The company has a market cap of $3.80 billion, a price-to-earnings ratio of 6.13, a PEG ratio of 1.14 and a beta of 0.94. The firm has a 50 day simple moving average of $24.07 and a 200 day simple moving average of $25.77.

Envista (NYSE:NVST – Get Free Report) last posted its earnings results on Wednesday, November 4th. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.04. The firm had revenue of $691.50 million for the quarter, compared to analysts’ expectations of $688.74 million. Envista had a net margin of 22.01% and a return on equity of 8.26%. The company’s revenue was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.32 earnings per share. Research analysts predict that Envista Holdings Corporation will post 1.56 earnings per share for the current fiscal year.

Envista Company Profile

(Free Report)

Envista Holdings Corporation is a dental products and technology company that develops and supplies tools and services for dental professionals. Its offerings span implant dentistry, orthodontics, digital imaging, restorative care and other clinical applications. The company’s products include dental implants and related treatment systems, orthodontic brackets and clear aligners, imaging equipment and software, and restorative and endodontic materials. Its brands include Nobel Biocare, Ormco, DEXIS, Kerr and KaVo.

Featured Articles

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.